ZH
KR
JP
ES
RU
DEimmune cells
immune cells, Total:112 items.
In the international standard classification, immune cells involves: Pharmaceutics, Vocabularies, Biology. Botany. Zoology, Medical sciences and health care facilities in general, Laboratory medicine, Cellular materials, Medical equipment, Quality, Fishing and fish breeding, Plastics, Dentistry, Education, Veterinary medicine, Farming and forestry, Microbiology.
Group Standards of the People's Republic of China, immune cells
- T/CGCPU 010-2020 Environmental requirements for the preparation of immune cell products
- T/CGCPU 011-2020 Quality Control Requirements for Immune Cell Products
- T/CGCPU 009-2020 Control requirements for the preparation process of immune cell products
- T/ZSA 150-2023 Management requirements for donor materials of immune cell product
- T/CGCPU 019-2022 Material management requirements for immune cell product donors
- T/SDHCST 008-2023 Procedures for Immunogenicity and Immunotoxicity of the Cell Therapy Medical Products
- T/XSMIA 0004-2022 Quality Accreditation of Immunocyte Preparation Center
- T/CEAC 044-2024 Safety management specifications for the separation, preparation and storage of immune cells
- T/CGCPU 027-2023 Design specifications for clinical research protocol of immunotherapy
- T/ZSA 146-2023 Technical requirements for Flow Cytometry validation of CD3、CD4、CD8 of immune cell product
- T/CGCPU 018-2022 Technical requirements for CD3, CD4, CD8 flow cytometric detection and verification of immune cell products
- T/FDSA 0055-2024 Guidelines for the development of Cell immunotherapy products based on mRNA-LNP technology
- T/CGCPU 028-2023 Requirements for quality control on non gene modified immune cells clinical research
- T/CI 390-2024 The technical regulation for preparation and clinical application of immuno-cell CIK from healthy person
- T/GDMDMA 0001-2022 Interleukin 6 Detection kit (Chemiluminescent Immunoassay)
- T/LNSI 004-2023 Human cytokine induced killer cell
- T/LNSI 004-2024 Human cytokine induced killer cell
- T/SHPPA 019-2023 Guidance for the manufacturing quality management of plasmids used in the production of Immune cell therapy products
- T/CRHA 002-2021 Human pluripotent stem cell derived small extracellular vesicles
- T/GDC 166-2022 Cell culture flask
- T/SHPPA 011-2021 Autologous CAR-T cell therapy medication supply chain management specifications
- T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry
- T/CECCEDA 003.1-2023 Technical requirement of single-use materials in CAR-T production Part 1: Cell frozen bag、Cell storage bag
- T/CRHA 001-2021 Human mesenchymal stem cell derived small extracellular vesicles
- T/CSCB 0007-2022 General requirements for production of extracellular vesicles derived from human stem cells
- T/GDC 213-2023 Cell Strainers
- T/QMHIPA 004-2022 Specification of Release Testing for Stem Cell-based Medicinal Products of Cell Preparation Center
- T/CSCB 0007-2021 Human cardiomyocyte
- T/GDC 207-2023 Cell and Tissue Culture Plates
- T/CSCB 0002-2020 Human embryonic stem cell
- T/GDC 262-2023 Tissue Culture Plate Insert
- T/GDC 263-2023 Cell and tissue culture dish
- T/GDC 212-2023 Cell Scrapers/Flat Blade Cell Lifter
- T/SRA 001-2019 Standards for establishment of seed cell bank of human adipose-derived mesenchymal stem cells
- T/CSCB 0008-2021 Primary human hepatocyte
- T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
- T/CSSCR 002-2019 human embryonic stem cells
Professional Standard - Agriculture, immune cells
- 259藥典 三部-2010 Appendix Ⅹ XR Anti-human T cell immunoglobulin titer assay (lymphocytotoxicity test)
- 1259藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs against Human T Cell Immunoglobulin
- 125藥典 三部-2020 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 113藥典 三部-2015 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 124藥典 三部-2020 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 114藥典 三部-2015 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 1258藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Anti-Human T Cell CD3 Mouse Monoclonal Antibody
- 327藥典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 274藥典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 279藥典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 91藥典 三部-2010 Chapter Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 92藥典 三部-2010 Chapter Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulin
- 298藥典 三部-2015 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test) General 129
- 77獸藥產(chǎn)品說明書范本第三冊-2013 Instructions for live vaccine swine fever live vaccine (cell source)
- 92獸藥典 三部-2015 Contents of the text live vaccines swine fever live vaccines (cell source)
- 1318藥典 化學(xué)藥和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Macrophage Stimulating Factor
- 584藥典 化學(xué)藥和生物制品卷-2010 Chapter VIII Drugs for Blood System Section 1 Drugs for Raising Blood Cells 2. Drugs for Raising Leukocytes Recombinant Human Granulocyte Macrophage Stimulating Factor
- 1252藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Rat Anti-Human T Lymphocyte CD3 Antigen Monoclonal Antibody
- 1311藥典 化學(xué)藥和生物制品卷-2010 Chapter 18 Biological Products 3. Blood Products Anti-Human T Cell Immunoglobulin
- SN/T 5041-2018 Quarantine technical specification for feline panleukopenia
- 916獸藥質(zhì)量標(biāo)準(zhǔn)2017年版 Biological Products Volume 1 Veterinary Drug Quality Standard Inactivated Cysticercus Porcine Cell Oil Emulsion Vaccine (CC-97 Cell Line)
Hebei Provincial Standard of the People's Republic of China, immune cells
- DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy
American Society for Testing and Materials (ASTM), immune cells
- ASTM F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
- ASTM F1906-98 Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
- ASTM F3354-19 Standard Guide for Evaluating Extracellular Matrix Decellularization Processes
- ASTM D3576-20 Standard Test Method for Cell Size of Rigid Cellular Plastics
- ASTM E2526-22 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM E2526-08(2013) Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM E2526-08 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
- ASTM D6226-21 Standard Test Method for Open Cell Content of Rigid Cellular Plastics
國家藥監(jiān)局, immune cells
- YY/T 1465.6-2019 Methods for evaluating the immunogenicity of medical devices Part 6: Determination of animal spleen lymphocyte subpopulations by flow cytometry
KR-KS, immune cells
- KS M ISO 4590-2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
國家食品藥品監(jiān)督管理局, immune cells
- YY/T 1465.4-2017 Methods for evaluating the immunogenicity of medical devices Part 4: In vivo test of phagocytosis of chicken red blood cells by mouse peritoneal macrophages
Korean Agency for Technology and Standards (KATS), immune cells
Professional Standard - Hygiene , immune cells
- WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes
- WS/T 360-2011 Guidelines for peripheral lymphocyte subsets by flow cytometry
- WS/T 360-2024 Guidelines for detection of peripheral blood lymphocyte subsets by flow cytometry
CZ-CSN, immune cells
農(nóng)業(yè)農(nóng)村部, immune cells
Professional Standard - Aquaculture, immune cells
國家市場監(jiān)督管理總局、中國國家標(biāo)準(zhǔn)化管理委員會, immune cells
- GB/T 39730-2020 General requirements for cell counting—Flow cytometry
- GB/T 39729-2020 General requirements for measurement of cell purity—Flow cytometry
Professional Standard - Medicine, immune cells
Association Francaise de Normalisation, immune cells
- NF S91-142:1988 Dental implants. Cytocompatibility. Study of cellular proliferation.
- NF S91-145:1988 Dentistry. Dental implants. Cytocompatibility. Study of cells attachment and spreading on the biomaterial.
- NF U47-221:2010 Isolation on cell culture and identification by immunofluorescence of infectious haematopoietic necrosis virus of fish.
- NF S91-143:1988 Dental implants. Cytocompatibility. Study of total cellular proteins.
- NF S91-144:1988 Dental implants. Cytocompatibility. Evaluation of 51CR extracellular release.
American National Standards Institute （ANSI), immune cells
US-FCR, immune cells
British Standards Institution (BSI), immune cells
- BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
- BS ISO 24479:2024 Biotechnology. Cellular morphological analysis. General requirements and considerations for cell morphometry to quantify cell morphological features
National Health Commission of the People's Republic of China, immune cells
- WST 360:2011 Guidelines for detection of peripheral blood lymphocyte subsets by flow cytometry
Professional Standard - Education, immune cells
SCC, immune cells
German Institute for Standardization, immune cells
- DIN 58932-2:1998 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)
- DIN 58932-2:1998-06 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)